1-20 of 38
natural killer cells
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Selective drug combination vulnerabilities in STAT3- and TP53-mutant malignant NK cells

Elina Parri, Heikki Kuusanmäki, Daria Bulanova, Satu Mustjoki, Krister Wennerberg
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1862–1875.
https://doi.org/10.1182/bloodadvances.2020003300
Published: 2021
Includes: Supplemental data
Journal Articles

Antineoplastic and anti-inflammatory effects of bortezomib on systemic chronic active EBV infection

Mayumi Yoshimori, Haruna Shibayama, Ken-Ichi Imadome, Fuyuko Kawano, Ayaka Ohashi, Miwako Nishio, Norio Shimizu, Morito Kurata, Shigeyoshi Fujiwara, Ayako Arai
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1805–1815.
https://doi.org/10.1182/bloodadvances.2020002417
Published: 2021
Includes: Supplemental data
Journal Articles

Microenvironment immune reconstitution patterns correlate with outcomes after autologous transplant in multiple myeloma

Harsh Parmar, Morie Gertz, Emilie Ingrid Anderson, Shaji Kumar, Taxiarchis V. Kourelis
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1797–1804.
https://doi.org/10.1182/bloodadvances.2020003857
Published: 2021
Includes: Supplemental data
Journal Articles

Low-density PD-1 expression on resting human natural killer cells is functional and upregulated after transplantation

Zachary Davis, Martin Felices, Todd Lenvik, Sujan Badal, Joshua T. Walker, Peter Hinderlie, James L. Riley, Daniel A. Vallera, Bruce R. Blazar, Jeffrey S. Miller
Journal: Blood Advances
Blood Adv (2021) 5 (4): 1069–1080.
https://doi.org/10.1182/bloodadvances.2019001110
Published: 2021
Includes: Supplemental data
Journal Articles

Charge-altering releasable transporters enable phenotypic manipulation of natural killer cells for cancer immunotherapy

Aaron J. Wilk, Nancy Lynn-Benner Weidenbacher, Rosemary Vergara, Ole A. W. Haabeth, Ronald Levy, Robert M. Waymouth, Paul A. Wender, Catherine A. Blish
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4244–4255.
https://doi.org/10.1182/bloodadvances.2020002355
Published: 2020
Includes: Supplemental data
Journal Articles

Human NK cells prime inflammatory DC precursors to induce Tc17 differentiation

Maria A. Clavijo-Salomon, Rosalba Salcedo, Soumen Roy, Rodrigo X. das Neves, Amiran Dzutsev, Helioswilton Sales-Campos, Karen Steponavicius-Cruz Borbely, Lucia Silla, Jordan S. Orange, Emily M. Mace, José A. M. Barbuto, Giorgio Trinchieri
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3990–4006.
https://doi.org/10.1182/bloodadvances.2020002084
Published: 2020
Includes: Supplemental data
Journal Articles

Myeloma cells induce the accumulation of activated CD94 low NK cells by cell-to-cell contacts involving CD56 molecules

Chiara Barberi, Claudia De Pasquale, Alessandro Allegra, Giacomo Sidoti Migliore, Daniela Oliveri, Fabrizio Loiacono, Vanessa Innao, Caterina Musolino, Daniela Pende, Claudia Cantoni, Paolo Carrega, Maria Cristina Mingari, Stefania Campana, Guido Ferlazzo
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2297–2307.
https://doi.org/10.1182/bloodadvances.2019000953
Published: 2020
Includes: Supplemental data
Journal Articles

Inducible MyD88/CD40 synergizes with IL-15 to enhance antitumor efficacy of CAR-NK cells

Xiaomei Wang, Daniel L. Jasinski, Jan L. Medina, David M. Spencer, Aaron E. Foster, J. Henri Bayle
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1950–1964.
https://doi.org/10.1182/bloodadvances.2020001510
Published: 2020
Includes: Supplemental data
Journal Articles

Impact of exercise on the immune system and outcomes in hematologic malignancies

Andrea Sitlinger, Danielle M. Brander, David B. Bartlett
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1801–1811.
https://doi.org/10.1182/bloodadvances.2019001317
Published: 2020
Journal Articles

Diversity of peripheral blood human NK cells identified by single-cell RNA sequencing

Samantha L. Smith, Philippa R. Kennedy, Kevin B. Stacey, Jonathan D. Worboys, Annie Yarwood, Seungmae Seo, Everardo Hegewisch Solloa, Brandon Mistretta, Sujash S. Chatterjee, Preethi Gunaratne, Kimaada Allette, Ying-Chih Wang, Melissa Laird Smith, Robert Sebra, Emily M. Mace, Amir Horowitz, Wendy Thomson, Paul Martin, Steve Eyre, Daniel M. Davis
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1388–1406.
https://doi.org/10.1182/bloodadvances.2019000699
Published: 2020
Includes: Supplemental data
Journal Articles

Impact of graft sources on immune reconstitution and survival outcomes following allogeneic stem cell transplantation

Clinical Trials & Observations
Taiki Ando, Takayoshi Tachibana, Masatsugu Tanaka, Taisei Suzuki, Yasufumi Ishiyama, Satoshi Koyama, Eriko Ogusa, Ayumi Numata, Kenji Matsumoto, Heiwa Kanamori, Hideaki Nakajima
Journal: Blood Advances
Blood Adv (2020) 4 (2): 408–419.
https://doi.org/10.1182/bloodadvances.2019001021
Published: 2020
Includes: Supplemental data
Journal Articles

Donor and host coexpressing KIR ligands promote NK education after allogeneic hematopoietic stem cell transplantation

Xiang-Yu Zhao, Xing-Xing Yu, Zheng-Li Xu, Xun-Hong Cao, Ming-Rui Huo, Xiao-Su Zhao, Ying-Jun Chang, Yu Wang, Xiao-Hui Zhang, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang
Journal: Blood Advances
Blood Adv (2019) 3 (24): 4312–4325.
https://doi.org/10.1182/bloodadvances.2019000242
Published: 2019
Includes: Supplemental data
Journal Articles

A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation

Li Li, Han Chen, David Marin, Yuanxin Xi, Qi Miao, Jiangxing Lv, Pinaki Prosad Banerjee, Hila Shaim, May Daher, Rafet Basar, Nobuhiko Imahashi, Juan Jimenez, Bingqian Hu, Rohtesh S. Mehta, Lucila Nassif Kerbauy, Mecit Kaplan, Mayela Mendt, Gonca Ozcan, Elif Gokdemir, Mayra Hernandez Sanabria, Ye Li, Ken Chen, Jing Wang, Luis Muniz-Feliciano, Wei-Li Zhao, Richard E. Champlin, Elizabeth J. Shpall, Katayoun Rezvani
Journal: Blood Advances
Blood Adv (2019) 3 (23): 4117–4130.
https://doi.org/10.1182/bloodadvances.2019000835
Published: 2019
Includes: Supplemental data
Journal Articles

CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML

Bérengère Salomé, Alejandra Gomez-Cadena, Romain Loyon, Madeleine Suffiotti, Valentina Salvestrini, Tania Wyss, Giulia Vanoni, Dan Fu Ruan, Marianna Rossi, Alessandra Tozzo, Paolo Tentorio, Elena Bruni, Carsten Riether, Eva-Maria Jacobsen, Peter Jandus, Curdin Conrad, Manfred Hoenig, Ansgar Schulz, Katarzyna Michaud, Matteo Giovanni Della Porta, Silvia Salvatore, Ping-Chih Ho, David Gfeller, Adrian Ochsenbein, Domenico Mavilio, Antonio Curti, Emanuela Marcenaro, Alexander Steinle, Amir Horowitz, Pedro Romero, Sara Trabanelli, Camilla Jandus
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3674–3687.
https://doi.org/10.1182/bloodadvances.2018030478
Published: 2019
Includes: Supplemental data
Journal Articles

Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment

Clinical Trials & Observations
Iris de Weerdt, Tom Hofland, Renate de Boer, Johan A. Dobber, Julie Dubois, Denise van Nieuwenhuize, Mehrdad Mobasher, Fransien de Boer, Mels Hoogendoorn, Gerjo A. Velders, Marjolein van der Klift, Ester B. M. Remmerswaal, Frederike J. Bemelman, Carsten U. Niemann, Sabina Kersting, Mark-David Levin, Eric Eldering, Sanne H. Tonino, Arnon P. Kater
Journal: Blood Advances
Blood Adv (2019) 3 (17): 2642–2652.
https://doi.org/10.1182/bloodadvances.2019000360
Published: 2019
Includes: Supplemental data
Journal Articles

The association of CMV with NK-cell reconstitution depends on graft source: results from BMT CTN-0201 samples

Clinical Trials & Observations
Armin Rashidi, Xianghua Luo, Sarah Cooley, Claudio Anasetti, Edmund K. Waller, Claudio G. Brunstein, Frank Cichocki, Daniel J. Weisdorf, Jeffrey S. Miller
Journal: Blood Advances
Blood Adv (2019) 3 (16): 2465–2469.
https://doi.org/10.1182/bloodadvances.2019000298
Published: 2019
Includes: Supplemental data
Journal Articles

Dinaciclib enhances natural killer cell cytotoxicity against acute myelogenous leukemia

Hyun Don Yun, Dawn K. Schirm, Martin Felices, Jeffrey S. Miller, Craig E. Eckfeldt
Journal: Blood Advances
Blood Adv (2019) 3 (16): 2448–2452.
https://doi.org/10.1182/bloodadvances.2019000064
Published: 2019
Journal Articles

First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia

Clinical Trials & Observations
Sarah Cooley, Fiona He, Veronika Bachanova, Gregory M. Vercellotti, Todd E. DeFor, Julie M. Curtsinger, Paul Robertson, Bartosz Grzywacz, Kevin C. Conlon, Thomas A. Waldmann, David H. McKenna, Bruce R. Blazar, Daniel J. Weisdorf, Jeffrey S. Miller
Journal: Blood Advances
Blood Adv (2019) 3 (13): 1970–1980.
https://doi.org/10.1182/bloodadvances.2018028332
Published: 2019
Includes: Supplemental data
Journal Articles

Human peripheral blood DNAM-1 neg NK cells are a terminally differentiated subset with limited effector functions

Kimberley A. Stannard, Sébastien Lemoine, Nigel J. Waterhouse, Frank Vari, Lucienne Chatenoud, Maher K. Gandhi, Ludovic Martinet, Mark J. Smyth, Camille Guillerey
Journal: Blood Advances
Blood Adv (2019) 3 (11): 1681–1694.
https://doi.org/10.1182/bloodadvances.2018030676
Published: 2019
Includes: Multimedia, Supplemental data
Journal Articles

Constitutive expression of ULBP-4 on monocytes regulates NK cell NKG2D expression

Neekun Sharma, Mary A. Markiewicz
Journal: Blood Advances
Blood Adv (2019) 3 (10): 1563–1567.
https://doi.org/10.1182/bloodadvances.2018025742
Published: 2019
Includes: Supplemental data